Segments - Maternal Health Market by Applications (Clinics, Home Care, Hospitals, and Others), Types of Pregnancy (Ectopic, Intrauterine, and Tubal), Types (Hormones, Nutritive, Anti-infective, Analgesics, and Others), Delivery Types (Cesarian Section, Vaginal Delivery, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global maternal health market size was valued at USD 30.18 Billion in 2022 and is projected to reach USD 63.15 Billion by 2031, expanding at a CAGR of 8.55% during the forecast period 2023-2031. The growth of the market is attributed to the increasing awareness regarding maternal health among people and its advantages.
Maternal health is referred as women's health during pregnancy, childbirth, and the postpartum period. Maternal health encompasses healthcare components of family planning, prenatal, preconception, and postnatal care to promote a positive and gratifying experience. It also reduces maternal morbidity and death. Excessive blood loss, high blood pressure, unsafe abortion, infection, and obstructed labor are prevalent direct causes of injury and death among women, while indirect factors include anemia, malaria, and heart diseases.
A majority of maternal deaths can be avoided if qualified health practitioners worked in a supportive atmosphere. The COVID-19 pandemic has caused widespread disruption in healthcare workflows around the world. Various industries, including several sub-domains of the healthcare industry, have been forced to temporarily stop their operations due to the spread of Coronavirus disease. Furthermore, several healthcare services, notably the mother and child healthcare, have suffered unfavorable consequences.
The pandemic produced substantial disruptions in the global pharmaceutical and medical supply chain. Although COVID-19 death rates in children and women of reproductive age appear to be low, these groups are expected to disproportionately affect due to inefficient routine health services, particularly in low- and middle-income country such as India.
Increasing adoption of mother healthcare services is expected to drive the market.
Rising need for parents to seek opinions from super-specialists is projected to propel the market during the forecast period.
Supply chain disruption of medicine and drugs in rural area is anticipated to hinder the market.
Limited availability of treatment options is expected to hamper the market in the coming years.
Rising disposable income and growing birth rates are projected to create lucrative opportunities in the market.
The report on the global maternal health market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Maternal Health Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Applications (Clinics, Home Care, Hospitals, and Others), Types of Pregnancy (Ectopic, Intrauterine, and Tubal), Types (Hormones, Nutritive, Anti-infective, Analgesics, and Others), and Delivery Types (Cesarian Section, Vaginal Delivery, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
MedTech Boston; Merck Sharp & Dohme Corp.; RAND Corporation; SYNAPSE; International Federation; Agile Therapeutics; Johnson & Johnson Services, Inc.; Jiovio Healthcare; and McKinsey & Company |
On the basis of applications, the maternal health market is segmented into clinics, home care, hospitals, and others. The hospitals segment is projected to expand at a considerable CAGR during the forecast period, due to rising birth rate. The clinics segment is anticipated to account for a major share of the market during the forecast period, owing to rising disposable income.
Based on types of pregnancies, the market is divided into ectopic, intrauterine, and tubal. The ectopic segment is expected to hold a significant share of the market in the coming years, due to rising number of pregnancies. The tubal segment accounts for a significant share of the market, owing to the increasing awareness among customers regarding advantages of maternal health.
On the basis of types, the maternal health market is segregated into hormones, nutritive, anti-infective, analgesics, and others. The hormones segment is anticipated to expand at a substantial CAGR during the forecast period, owing to robust R&D activities. The anti-infective segment is expected to hold a significant share of the market, due to increasing incidences of sexually transmitted diseases.
Based on delivery types, the market is categorized as Cesarean section, vaginal delivery, and others. The vaginal delivery segment is projected to constitute a considerable share of the market in the coming years, due to the increasing number of emergency referral system. Rising number of lifestyle ailments are causing complications during delivery, thus many healthcare professionals and mothers opt for Cesarean section, which in turn is fueling the growth of the segment.
In terms of regions, the global maternal health market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the forecast period, owing to increasing disposable income. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period, due to the rising presence of numerous companies in countries such as China and India, growing prevalence of gynecological ailments, and increasing population.
The global maternal health market has been segmented on the basis of
Key players operating in the global maternal health market are MedTech Boston; Merck Sharp & Dohme Corp.; RAND Corporation; SYNAPSE; International Federation; Agile Therapeutics; Johnson & Johnson Services, Inc.; Jiovio Healthcare; and McKinsey & Company
Product launches and organic growth strategies, such as participation in events, are being prioritized by a number of companies. These companies also adopt acquisitions and collaborations to increase the growth of the market.
Key players competing in the global maternal health market are MedTech Boston; Merck Sharp & Dohme Corp.; RAND Corporation; SYNAPSE; International Federation; Agile Therapeutics; Johnson & Johnson Services, Inc.; Jiovio Healthcare; and McKinsey & Company
North America is expected to constitute a key share of the market during the forecast period, owing to increasing disposable income.
The global maternal health market is anticipated to expand at a CAGR of 8.55% during the forecast period, 2022–2030.
Rising need for parents to seek opinion from super-specialists is projected to propel the market during the forecast period.
The global maternal health market size was valued at around USD 27,839 million in 2021 during the forecast period, 2022–2030.